Benjamin J. Schürmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Benjamin J. Schürmann has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Schmitz-Rode
Institute of Applied Medical Engineering Medical Faculty RWTH Aachen University Aachen Germany
4 shared publications - Johanna Charlotte Clauser
Department of Cardiovascular Engineering, Institute of Applied Medical Engineering University Hospital RWTH Aachen University Aachen Germany
3 shared publications - Ulrich Steinseifer
Department of Cardiovascular Engineering, Institute of Applied Medical Engineering University Hospital RWTH Aachen University Aachen Germany
3 shared publications - Pia Creutz
Department of Cardiovascular Engineering, Institute of Applied Medical Engineering University Hospital RWTH Aachen University Aachen Germany
2 shared publications - Bennet F. Holst
Department of Cardiovascular Engineering Institute of Applied Medical Engineering, University Hospital RWTH Aachen University Aachen Germany
1 shared publication - Georg Wagner
Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany
1 shared publication
Latest Publications
- Open Access
- 24 July 2025
- Published by Wiley in Artificial Organs
- Vol. 49 (10) , 1540-1547
Ghost Cells as a Two‐Phase Blood Analog Fluid —Fluorescent Mechanical Hemolysis Detection
Background: This study investigated fluorescent hemolysis detection as an optical method to detect local hemolysis in mechanical circulatory support systems, addressing the limitations of standard hemolysis tests and current simulation methods. Standard tests, per ASTM1841‐19, quantify general hemolysis but do not localize it. Methods: We employ a two‐phase blood analog fluid composed of calcium‐loaded ghost cells and phosphate‐buffered saline. Ghost cells are hemoglobin‐depleted red blood cells, allowing for optical measurements. A calcium‐sensitive fluorescent indicator (Cal590 potassium salt, AAT Bioquest, Pleasanton, USA), activated by calcium released upon ghost cell hemolysis, enables fluorescent hemolysis detection. Hemolysis tests were conducted using porcine whole blood and the blood analog fluid, confirming that both undergo mechanical hemolysis in the Food and Drug Administration pump model. Results: The results revealed increased fluorescence intensity in response to hemolysis, with a quantitative fluorescence increase of 8.85/min at 3500 rpm and 2.5 L/min, indicating hemolysis, particularly at the rotor tip. Through image processing of fluorescence images, local hemolysis was visualized. Conclusion: This study is the first to use fluorescent hemolysis detection for local detection of mechanical hemolysis. Further refinement may enhance the design of mechanical circulatory support systems and bridge simulation limitations with experimental, localized hemolysis detection.
- 24 July 2025
- Published by Wiley in Artificial Organs
- Vol. 49 (10) , 1540-1547
Open AccessGhost Cells as a Two‐Phase Blood Analog Fluid —Fluorescent Mechanical Hemolysis Detection
Background: This study investigated fluorescent hemolysis detection as an optical method to detect local hemolysis in mechanical circulatory support systems, addressing the limitations of standard hemolysis tests and current simulation methods. Standard tests, per ASTM1841‐19, quantify general hemolysis but do not localize it. Methods: We employ a two‐phase blood analog fluid composed of calcium‐loaded ghost cells and phosphate‐buffered saline. Ghost cells are hemoglobin‐depleted red blood cells, allowing for optical measurements. A calcium‐sensitive fluorescent indicator (Cal590 potassium salt, AAT Bioquest, Pleasanton, USA), activated by calcium released upon ghost cell hemolysis, enables fluorescent hemolysis detection. Hemolysis tests were conducted using porcine whole blood and the blood analog fluid, confirming that both undergo mechanical hemolysis in the Food and Drug Administration pump model. Results: The results revealed increased fluorescence intensity in response to hemolysis, with a quantitative fluorescence increase of 8.85/min at 3500 rpm and 2.5 L/min, indicating hemolysis, particularly at the rotor tip. Through image processing of fluorescence images, local hemolysis was visualized. Conclusion: This study is the first to use fluorescent hemolysis detection for local detection of mechanical hemolysis. Further refinement may enhance the design of mechanical circulatory support systems and bridge simulation limitations with experimental, localized hemolysis detection.
- Open Access
- 18 June 2025
- Published by Wiley in Artificial Organs
- Vol. 49 (10) , 1532-1539
Ghost Cells as a Two‐Phase Blood Analog Fluid—Optical Thrombus Growth Detection Using Particle Image Velocimetry
Background: In vitro thrombosis tests for mechanical circulatory support systems lack standardized ISO guidelines. A major limitation of current approaches is the absence of continuous thrombus monitoring, as terminated experiments at a single time point fail to capture the dynamic nature of thrombus formation. However, spatially resolved thrombus formation and its underlying dynamics are crucial for the optimization of mechanical circulatory support systems. Methods: In this study, we present a high‐resolution thrombus monitoring approach using particle image velocimetry with a thrombogenic, two‐phase blood analog fluid, designated as “ghost blood”. Ghost blood consists of plasma and ghost cells, which are hemoglobin‐depleted erythrocytes. We validate and quantify the particle image velocimetry with ghost blood and use this combination to monitor thrombus growth. Results: The validation demonstrated velocity fields in the FDA‐pump are consistent with existing literature, confirming the usability of ghost blood in particle image velocimetry. The use range of ghost blood is quantified as a formula to determine the maximum possible optical penetration depth. Finally, thrombus growth was successfully monitored in the FDA‐pump. Conclusion: In this proof of principle study, we grew a thrombus in the FDA‐pump and were able to monitor its growth from a first thrombus thread to a complete obstruction of the flow. This approach enables both the localization and the temporal growth of the thrombus to be visualized and thereby provides a foundation for future advancements in thrombosis assessment and the optimization of mechanical circulatory support systems.
- 18 June 2025
- Published by Wiley in Artificial Organs
- Vol. 49 (10) , 1532-1539
Open AccessGhost Cells as a Two‐Phase Blood Analog Fluid—Optical Thrombus Growth Detection Using Particle Image Velocimetry
Background: In vitro thrombosis tests for mechanical circulatory support systems lack standardized ISO guidelines. A major limitation of current approaches is the absence of continuous thrombus monitoring, as terminated experiments at a single time point fail to capture the dynamic nature of thrombus formation. However, spatially resolved thrombus formation and its underlying dynamics are crucial for the optimization of mechanical circulatory support systems. Methods: In this study, we present a high‐resolution thrombus monitoring approach using particle image velocimetry with a thrombogenic, two‐phase blood analog fluid, designated as “ghost blood”. Ghost blood consists of plasma and ghost cells, which are hemoglobin‐depleted erythrocytes. We validate and quantify the particle image velocimetry with ghost blood and use this combination to monitor thrombus growth. Results: The validation demonstrated velocity fields in the FDA‐pump are consistent with existing literature, confirming the usability of ghost blood in particle image velocimetry. The use range of ghost blood is quantified as a formula to determine the maximum possible optical penetration depth. Finally, thrombus growth was successfully monitored in the FDA‐pump. Conclusion: In this proof of principle study, we grew a thrombus in the FDA‐pump and were able to monitor its growth from a first thrombus thread to a complete obstruction of the flow. This approach enables both the localization and the temporal growth of the thrombus to be visualized and thereby provides a foundation for future advancements in thrombosis assessment and the optimization of mechanical circulatory support systems.
- Open Access
- 27 August 2024
- Published by Wiley in Artificial Organs
- Vol. 49 (1) , 31-38
Ghost cells as a two‐phase blood analog fluid: high‐volume and high‐concentration production
Background: Hemolysis in mechanical circulatory support systems is currently determined quantitatively. To also locally resolve hemolysis, we are developing a fluorescent hemolysis detection method. This requires a translucent two‐phase blood analog fluid combined with particle image velocimetry, an optical flow field measurement. The blood analog fluid is composed of red blood cell surrogates. However, producing surrogates in sufficient volume is a challenge. We therefore present a high‐volume and high‐concentration production for our surrogates: ghost cells, hemoglobin‐depleted erythrocytes. Methods: In the ghost cell production, the hemoglobin is removed by a repeated controlled osmolar lysis. We have varied the solution mixture, centrifugation time, and centrifugation force in order to increase production efficiency. The production is characterized by measurements of output volume, hematocrit, transparency, and rheology of the blood analog fluid. Results: The volume of produced ghost cells was significantly increased, and reproducibility was improved. An average production of 389 mL of ghost cells were achieved per day. Those ghost cells diluted in plasma have a rheology similar to blood while being permeable to light. Conclusion: The volume of ghost cells produced is sufficient for optical measurements as particle image velocimetry in mechanical circulatory support systems. This makes further work on experimental measurements for a locally resolved hemolysis detection possible.
- 27 August 2024
- Published by Wiley in Artificial Organs
- Vol. 49 (1) , 31-38
Open AccessGhost cells as a two‐phase blood analog fluid: high‐volume and high‐concentration production
Background: Hemolysis in mechanical circulatory support systems is currently determined quantitatively. To also locally resolve hemolysis, we are developing a fluorescent hemolysis detection method. This requires a translucent two‐phase blood analog fluid combined with particle image velocimetry, an optical flow field measurement. The blood analog fluid is composed of red blood cell surrogates. However, producing surrogates in sufficient volume is a challenge. We therefore present a high‐volume and high‐concentration production for our surrogates: ghost cells, hemoglobin‐depleted erythrocytes. Methods: In the ghost cell production, the hemoglobin is removed by a repeated controlled osmolar lysis. We have varied the solution mixture, centrifugation time, and centrifugation force in order to increase production efficiency. The production is characterized by measurements of output volume, hematocrit, transparency, and rheology of the blood analog fluid. Results: The volume of produced ghost cells was significantly increased, and reproducibility was improved. An average production of 389 mL of ghost cells were achieved per day. Those ghost cells diluted in plasma have a rheology similar to blood while being permeable to light. Conclusion: The volume of ghost cells produced is sufficient for optical measurements as particle image velocimetry in mechanical circulatory support systems. This makes further work on experimental measurements for a locally resolved hemolysis detection possible.
- Open Access
In Vitro and In Vivo Feasibility Study for a Portable VV-ECMO and ECCO2R System
Extracorporeal membrane oxygenation (ECMO) is an established rescue therapy for patients with chronic respiratory failure waiting for lung transplantation (LTx). The therapy inherent immobilization may result in fatigue, consecutive deteriorated prognosis, and even lost eligibility for transplantation. We conducted a feasibility study on a novel system designed for the deployment of a portable ECMO device, enabling the physical exercise of awake patients prior to LTx. The system comprises a novel oxygenator with a directly connected blood pump, a double-lumen cannula, gas blender and supply, as well as control and energy management. In vitro experiments included tests regarding performance, efficiency, and blood damage. A reduced system was tested in vivo for feasibility using a novel large animal model. Six anesthetized pigs were first positioned in supine position, followed by a 45° angle, simulating an upright position of the patients. We monitored performance and vital parameters. All in vitro experiments showed good performance for the respective subsystems and the integrated system. The acute in vivo trials of 8 h duration confirmed the results. The novel portable ECMO-system enables adequate oxygenation and decarboxylation sufficient for, e.g., the physical exercise of designated LTx-recipients. These results are promising and suggest further preclinical studies on safety and efficacy to facilitate translation into clinical application.
Open AccessIn Vitro and In Vivo Feasibility Study for a Portable VV-ECMO and ECCO2R System
Extracorporeal membrane oxygenation (ECMO) is an established rescue therapy for patients with chronic respiratory failure waiting for lung transplantation (LTx). The therapy inherent immobilization may result in fatigue, consecutive deteriorated prognosis, and even lost eligibility for transplantation. We conducted a feasibility study on a novel system designed for the deployment of a portable ECMO device, enabling the physical exercise of awake patients prior to LTx. The system comprises a novel oxygenator with a directly connected blood pump, a double-lumen cannula, gas blender and supply, as well as control and energy management. In vitro experiments included tests regarding performance, efficiency, and blood damage. A reduced system was tested in vivo for feasibility using a novel large animal model. Six anesthetized pigs were first positioned in supine position, followed by a 45° angle, simulating an upright position of the patients. We monitored performance and vital parameters. All in vitro experiments showed good performance for the respective subsystems and the integrated system. The acute in vivo trials of 8 h duration confirmed the results. The novel portable ECMO-system enables adequate oxygenation and decarboxylation sufficient for, e.g., the physical exercise of designated LTx-recipients. These results are promising and suggest further preclinical studies on safety and efficacy to facilitate translation into clinical application.